9 completed, 1 recruiting. 10 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 9, Recruiting 1 |
Follow follitropin delta: new trials by email Literature Review of follitropin delta trials Research Report on follitropin delta
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST) Human chorionic gonadotropin (hCG), Follitropin delta, Triptorelin - Low Ovarian Reserve, Poor Ovarian Response | Phase 3 | Recruiting | Fundación para la Investigación del Hospital Clínico de Valencia | 126 | 2024-09-17 | 2026-09-11 |
| A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China FE 999049, GONAL-F - Infertility, Female | Phase 3 | Completed | Ferring Pharmaceuticals | 301 | 2024-03-29 | 2026-02-12 |
| A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation REKOVELLE (Follitropin Delta), GONAL-F (Follitropin Alfa) - Infertility | Phase 3 | Completed | Ferring Pharmaceuticals | 302 | 2022-07-15 | 2025-04-02 |
| Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Women Follitropin Delta (FE 999049), Follitropin Alfa (GONAL-F) - Infertility | Phase 3 | Completed | Ferring Pharmaceuticals | 220 | 2021-12-03 | 2025-01-24 |
| Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2) Follitropin delta, Placebo - Infertility, Female | Phase 3 | Completed | Ferring Pharmaceuticals | 588 | 2018-10-29 | 2024-01-18 |
| Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1) Follitropin delta, Placebo - Infertility | Phase 3 | Completed | Ferring Pharmaceuticals | 579 | 2018-10-26 | 2024-01-18 |
| Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women Follitropin alfa, Follitropin delta - Controlled Ovarian Simulation | Phase 3 | Completed | Ferring Pharmaceuticals | 1011 | 2017-12-01 | 2023-08-24 |
| Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women Follitropin delta, Follitropin beta - Infertility | Phase 3 | Completed | Ferring Pharmaceuticals | 373 | 2017-07-29 | 2023-08-24 |
| Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2 Follitropin Delta (FE 999049), Follitropin Alfa (GONAL-F) - Infertility | Phase 3 | Completed | Ferring Pharmaceuticals | 513 | 2014-03-26 | 2023-09-06 |
| Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1 Follitropin Delta (FE 999049), Follitropin Alfa (GONAL-F) - Infertility | Phase 3 | Completed | Ferring Pharmaceuticals | 1329 | 2013-10-01 | 2022-01-13 |
Infertility (6) · Infertility, Female (2)
Ferring Pharmaceuticals (9) · Fundación para la Investigación del Hospital Clínico de Valencia (1)
Spain (4) · France (3) · Italy (3) · United Kingdom (3) · Belgium (2) · Brazil (2) · Canada (2) · China (2) · Czechia (2) · Denmark (2) · Poland (2) · Russia (2) · United States (2) · Austria (1) · India (1)
PMID 37156263, PMID 30801744, PMID 34254211, PMID 34799275, PMID 40714031, PMID 27912901, PMID 32819842, PMID 33722477, PMID 34179971, PMID 36195924, PMID 40633120